GTR 111833561

Bids Are Invited For Acquisition Of Oncological Medications To Meet The Needs Of Hugg And Huse.

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
111833561
Tendering Authority
Subscribe to view
Tender No
96108/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Oncological Medications To Meet The Needs Of Hugg And Huse.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
05-05-2026 Closed
Work Detail
Acquisition Of Oncological Medications To Meet The Needs Of Hugg And Huse.. Abiraterone Acetate,Cyproterone Acetate,Lanreotide Acetate,Octreotide,Octreotide,Octreotide,Zoledronic Acid,Anagrelide Hydrochloride,Anastrozole,Apalutamide,Azacytidine,Bevacizumab,Bevacizumab,Bicalutamide,Bleomycin Sulfate,Bortezomib,Brentuximab Vedotin,Capecitabine,Carboplatin,Carboplatin,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cisplatin,Cisplatin,Cytarabine,Cladribine,Chlorambucil,Daunorubicin,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Idarubicin Hydrochloride,Mitoxantrone Hydrochloride,Ondansetron Hydrochloride,Ondansetron Hydrochloride,Ondansetron Hydrochloride,Topotecan Hydrochloride,Dacarbazine,Dactinomycin,Dasatinib,Dasatinib,Docetaxel,Docetaxel,Eltrombopag Olamine,Enzalutamide,Erlotinib,Etoposide,Exemestane,Fluoruracil,Fluoruracil,Calcium Folinate,Calcium Folinate,Fosaprepitant Dimeglumine,Fludarabine Phosphate,Fulvestrant,Gefitinib,Gemcitabine Hydrochloride,Gemcitabine Hydrochloride,Goserelin Acetate, Hydroxyurea, Ifosfamide, Ifosfamide, Imatinib Mesylate, Infliximab, Irinotecan Hydrochloride, Lenvatinib, Megestrol Acetate,Melphalan,Mercaptopurine,Mesna,Mesna,Methotrexate,Methotrexate,Methotrexate,Methotrexate,Probiotic,Nilotinib,Oxaliplatin,Oxaliplatin,Paclitaxel,Paclitaxel,Paclitaxel,Palbociclib,Palbociclib,Palbociclib,Palonosetron Hydrochloride,Pamidronate Sodium,Pazopanib,Pegaspargase,Pembrolizumab,Pemetrexed,Pertuzumab,Rasburicase,Regorafenib,Ribociclib,Rituximab,Rituximab,Sorafenib Tosylate,Sunitinib,Tamoxifen Citrate
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
680debe1-020e-4016-8cff-7aa79a6d6b04.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders